Jiangmen Central Hospital
🇨🇳China
Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma
Phase 2
- Conditions
- Advanced Cholangiocarcinoma
- Interventions
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Jiangmen Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03982680
- Locations
- 🇨🇳
Jiangmen central hospital, Jiangmen, Guangdong, China
The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Jiangmen Central Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT01732276
© Copyright 2025. All Rights Reserved by MedPath